Skip to content
Open access

Canine brain imaging with a new low-field portable (0.05 T) MRI scanner: a pilot in vivo comparison to conventional 1.5 T

Jul 2026 · Veterinary Quarterly · Vol 46 · 0 citations · 51 references
Medicine

TL;DR

This pilot study successfully translated a previously developed LF MRI canine cadaver brain protocol for in vivo application and compared the acquired images with paired 1.5 T MRI images from 21 different canine patients, representing the first in vivo usage and evaluation of a 0.05 T MRI in a clinical veterinary context.

Abstract

ABSTRACT Prohibitive costs associated with high-field MRI systems have resulted in reduced access in resource-limited areas with consequential healthcare inequities. This has renewed interest in purposefully designed low-field (LF) systems that, despite inherently lower signal-to-noise ratios, have advantages in terms of cost, portability, and accessibility. This pilot study successfully translated a previously developed LF (0.05 T) MRI canine cadaver brain protocol for in vivo application and compared the acquired images with paired 1.5 T images from 21 different canine patients. The visibility of 15 anatomic features was ordinarily scored (scale 1–3) on transverse T1-weighted post-contrast (21/21 patients) and T2-weighted (17/21 patients) sequences. Lateral ventricles were easily visualized (89.3%–100% scored 3/3) across all sequence‒system combinations, with T2-weighted sequences also providing good identification of the mesencephalic aqueduct (56.3%–100%), fourth ventricle (77.1%–100%), and thalamus (68.8%–100%). Absolute visual grading characteristics (VGC) analysis confirmed comparable performance of the LF system to the 1.5 T MRI for these features, a particularly relevant finding given the system's originally intended application for pediatric hydrocephalus neuroimaging in resource-limited areas. This study represents the first in vivo usage and evaluation of a 0.05 T MRI in a clinical veterinary context.

Read PDF

Similar papers

Review Jul 2026

Ultra-Low-Field Brain MRI for Point-of-Care Applications: A Technology Review.

The recent developments in ultra-low-field brain MRI are reviewed, which enable imaging in open environments and demonstrate initial clinical applicability in point-of-care settings, and future developments are envisioned to address the current limitations of image quality and contrast in ultra-low-field brain MRI syst...

Ed X. Wu, Yujiao Zhao, Yilong Liu et al. · 1 citation
Open access Aug 2026

Reproducibility of Volumetric Analysis using Ultra-Low-Field Portable Magnetic Resonance Imaging

Qualitative similarities between volume measurements in adults and the questions of reproducibility through test-retest reliability and external validity using recent software updates to the Hyperfine Swoop system constitute a crucial foundation for the clinical utility of 64 mT MRI in monitoring brain volume loss over...

M. Stockbridge, Rex Wang, V. Neal et al. · 0 citations
Open access Jul 2026

Deep Learning-Based Image Enhancement of Low-Field Brain MRI: A Multicenter Validation of Diagnostic Image Quality and Lesion Detection

A deep-learning framework for image normalisation and noise reduction to elevate 0.35T brain MRI toward high-field standards with almost-perfect reader agreement is developed and validated and is a low-cost route to more equitable neuroimaging.

Rachmat Hidayat, Linda Purnama · 0 citations
Open access Aug 2026

Comparative Evaluation of Single-Voxel and Multi-Voxel Proton Magnetic Resonance Spectroscopy Using Small-Sized Voxels in Healthy Beagle Dogs: A Pilot Study

While small-voxel SVS is technically feasible and reduces scan time, these findings represent protocol-specific descriptive data in a small sample of healthy dogs and do not establish clinical reference values or diagnostic accuracy.

Jong-Bong Lee, Gunha Hwang, Seokmin Lee et al. · 0 citations
Review Open access Aug 2026

Non-contrast renal MR angiography: a within-subject comparison of imaging performance at 1.5 T, 3 T, and 5 T

These findings provide quantitative baseline data for normal renal vasculature and support further clinical validation of NC-MRA protocols in patients with renal artery disease or contraindications to gadolinium-based contrast agents.

An-Jie Xie, Min Li, Jia-Qi Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.